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Introduction
Increases in longevity along with improved management of chronic conditions have led to more people
living to very old ages with one or more chronic conditions [1].  The prevalence of most chronic conditions
is projected to increase; by 2035, over half the population aged over 85 years will have four or more
chronic conditions [2]. Consequently, interest is increasing in the associations of chronic conditions and
multimorbidity with different health outcomes.
The prevalence of multimorbidity, defined as having more than one chronic condition, peaks around age
85, with reported prevalence rates ranging from 82% to 95% [3–5]. In studies mostly concerning younger
people, multimorbidity has been associated with declining functional ability, lower quality of life and high
need for health care services [6].
Most studies have shown higher mortality for people with several chronic conditions, but in old age, this
association is thought to be mediated by functional ability [7]. Disability and chronic conditions are closely
related and often co-occur in old age, reflecting the severity of chronic conditions. However, functioning
seems to decrease in old age irrespective of a person’s disease status [8]. Currently, knowledge about the
predictors of mortality among the oldest old is limited. In a Danish study, chronic conditions had little effect
on mortality [9], whereas in another study low baseline comorbidity was associated with low 5-year
mortality [10].
The need for long-term care (LTC) rises during the last years or months of life. Time spent in LTC during the
end of life seems to have increased, possibly since people are living longer and suffering from more chronic
conditions than before [11]. In younger old people, dementia and Parkinson’s disease, as well as
multimorbidity, have been associated with the need for LTC [12, 13].  Prior research is scarce on chronic
conditions or multimorbidity as predictors of LTC use in the oldest old population.
The study examines to what extent chronic conditions and multimorbidity predict mortality and LTC
admission in the population aged 90 and over, and assesses the population attributable fractions of
mortality and LTC admission for individual chronic conditions.
Methods 
Sample 
The data were based on four cross-sectional waves of the Vitality 90+ Study conducted in 2001, 2003, 2007 
and 2010 [14]. Each study year the mailed survey included both community-dwelling and institutionalized 
residents aged 90 years and over in the city of Tampere, Finland (in 2017 with 231,853 inhabitants, of 
whom 19% were aged over 65 and 0.9% aged over 90 [15]). The response rate varied between 79% and 
86%. Due to high mortality, most participants (n = 1,650) responded to only one survey. Of the remainder, 
1,004 participated in two surveys, 176 three surveys and 32 all four surveys. The sample used in the 
analysis concerning mortality included 2,862 participants (79.5% women). The LTC analysis used a 
subsample of 1,954 respondents living in their own homes at baseline. Proxy answers were included for 
participants who could not answer the questionnaire themselves.  
Chronic conditions 
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Information on chronic conditions was based on self-reports. Participants were asked whether a doctor had 
told them they had any of nine chronic conditions: hypertension, heart disease, dementia, stroke, diabetes, 
arthritis, Parkinson’s disease, hip fracture, and depression. To describe multimorbidity, the respondents 
were categorized as having 0, 1, 2, 3 and 4+ conditions.  
Covariates 
Functional ability was included in the analysis as a sum of five variables measuring activities of daily living 
and mobility. Participants were asked “Are you able to…” move indoors, walk at least 400 meters, use 
stairs, dress, and get in and out of bed. The answer choices were “Yes, without difficulty,” “Yes, but it’s 
difficult,” “Not without help” and “Unable.” Answers were scored from 1 (able without difficulty) to 4 
(unable). Hence, the total score for functional ability ranged from 5 (i.e., able to perform all activities 
without difficulty) to 20 (unable for all activities).  
Occupational class was used as a covariate since multimorbidity and certain chronic conditions tend to be 
more prevalent in people with lower socioeconomic status [3, 16]. The participant’s main occupation during 
working life was coded according to the Statistics Finland occupation classification [17] as upper non-
manual, lower non-manual, skilled manual, unskilled manual, housewives and unknown occupation.  
Other covariates used in the analysis were age and year entering the study. Additionally, living alone vs. 
with others was included as a covariate in LTC analysis.  
Outcomes 
The main outcomes in this study were death and entering LTC. LTC was defined as an approval for LTC 
admission from the municipal authorities or being at least 90 days in a residential home, service home with 
24-hour assistance or inpatient ward of a health center or hospital. Data for mortality and LTC were 
retrieved from the Finnish Population Register and the National Care Registers for Health and Social 
Welfare and were linked to the survey data using unique personal identity codes. The follow-up began on 
the index date of every study year and ended on December 31, 2012 at the latest.  
Permission to use pseudonymized register data was obtained from the National Institute for Health and 
Welfare and the data was formed with Statistics Finland. The ethics committees of Pirkanmaa Hospital 
District or the City of Tampere, depending on the study year, gave ethical statements for the Vitality 90+ 
Study.  
Statistical analysis 
Cox proportional hazard regression was used to estimate risk of death. In the analysis concerning LTC 
admission, competing risk regression [18] with death as a competing risk was used. Chronic conditions, 
functional ability and living arrangements were considered as time-dependent covariates using data from 
each participants’ all available survey rounds. Number of chronic conditions was also considered as a time-
dependent covariate. However, if a participant reported fewer conditions on a later survey round, the 
former number (i.e., the higher number) of conditions remained unchanged.  
First, the associations of each chronic condition and functional ability separately, with mortality, adjusted 
for age and year of entry, were analyzed. Second, all chronic conditions, functional ability, and occupational 
class, together with age and year of entry were included in the same model. The analyses concerning 
association between chronic conditions and entering LTC followed the same patterns but living alone was 
also included in the second model. Then similar analyses were performed to test the effects of 
multimorbidity. All analyses were conducted separately for men and women. Hazard ratios (HR) and sub-
hazard ratios (SHR) with 95% confidence intervals are presented.  
Population attributable fraction (PAF) was used to describe the burden of chronic conditions. PAF was 
computed based on the Cox and competing risk regression analyses [19]. These models, however, were 
adjusted only for age, year of entry and all conditions, in order to estimate purely the attribution of the 
chronic conditions. PAF takes into account not only the strength of a relationship between risk factor and 
outcome but also the prevalence of the risk factor in a population. Therefore, it describes the importance 
of certain risk factors at population level [20].  
P-values <0.5 were considered significant. Stata version 15.1 was used in all analyses. 
Results 
In total, 2,862 participants were included in the analyses concerning mortality. Of them 2,165 died (75.2% 
of women and 77.3% of men) during the follow-up. The average time to death was 2.5 years (range 9 days 
– 11.6 years). Of those living outside institutions at baseline (n = 1,954), 46.1% of women and 33.8% of men 
moved to LTC. The average follow-up time to LTC admission was 2.1 years (range 4 days - 11 years). 
Characteristics of participants at baseline are shown in Table 1. 
Chronic conditions and multimorbidity as predictors of mortality 
In the first model, dementia, stroke, diabetes, heart disease and depression increased the risk of death, 
whereas participants with arthritis had lower mortality. In addition, worse functional ability predicted 
mortality. The findings were similar for both genders (Table 2). 
In the fully adjusted model, heart disease, dementia and diabetes, but not stroke, increased the risk of 
death for both genders. In addition, depression was associated with an increased risk of death in women. In 
men, arthritis and Parkinson’s disease were associated with lower risk of death (Table 2).  
In the model adjusted for age and year of entry, there was a graded association between the number of 
conditions and the risk of death in both genders. When functional ability and occupational class were 
added, HRs declined but women with 3 or 4+ conditions still had increased risk of death (53% and 59% 
respectively). In the final model, having three or more conditions predicted mortality in women whereas 
the association was found in men only for those with one condition compared to men with no conditions 
(Table 2).   
Chronic conditions and multimorbidity as predictors of LTC admission 
Women with Parkinson’s disease, dementia, hip fracture or depression had an increased risk of LTC 
admission in both the first and fully adjusted models. In men, none of the conditions was associated with 
LTC admission; the only significant predictor was worse functional ability (Table 3).  
Having at least two conditions increased the risk of LTC admission in women when only age and year of 
entry were adjusted for. When functional ability, living alone and occupational class were taken into 
account, the risk of entering LTC increased by 64% for women having 3 conditions and 99% for women 
having 4+ conditions. In men, multimorbidity was not associated with LTC admission (Table 3). 
PAF of mortality and LTC admission 
In women 16% of deaths, and in men 14%, were attributable to heart disease. Corresponding numbers for 
dementia were 19% for women and 20% for men, and for diabetes, 3% for women and 5% for men. 
Depression accounted for 5% and stroke for 3% of deaths in women and hip fracture for 3% of deaths in 
men.  
In both genders, dementia had the highest PAF for entering LTC (8% in women and 9 % in men). In women, 
Parkinson’s disease had the lowest PAF (0.6%), though it was the strongest predictor of LTC admission in 
regression model (Table 3). PAF for hip fracture was 5% and for depression 4% (Supplementary table 1). 
  
 Discussion 
This follow-up study describes the associations of chronic conditions and multimorbidity with mortality and 
LTC admission in the fastest growing population segment in Europe: people aged over 90 years. The results 
show that certain individual conditions, as well as multimorbidity, predict mortality and LTC admission in 
this population independent of functional ability, age, living arrangements, socioeconomic status and 
cohort effect. Furthermore, a notable fraction of deaths is attributed to dementia, which also has the 
greatest effect on LTC admission. In men, chronic conditions and multimorbidity had weaker effects on the 
outcomes, at least partly due to the small number of male participants.  
In this study, heart disease in women and diabetes in men had the strongest association with mortality, in 
line with previous studies considering younger old people [21, 22]. Our findings support previous evidence 
that cardiovascular diseases are a significant cause of death still in old age [23]. However, in oldest old, 
dementia was a greater determinant of death than heart disease or diabetes at population level. An even 
greater PAF of dementia was observed in a previous study including people over 95 years old [24]. As 
advances in prevention and treatment of cardiovascular diseases improve survival and decrease 
cardiovascular mortality [23], increasing numbers of the oldest will be expected to suffer and die from 
dementia.  
Besides dementia and cardiovascular disease, depression was associated with mortality in women. Such an 
association has not been reported before in this age group. As causes of death were not studied, the 
mechanisms underlying the association between depression and mortality in the oldest old remain 
unknown. The lower risk of death for arthritis sufferers is not an unprecedented finding [22] yet contrasts 
with most studies on younger old people [25]. Both depression and arthritis in the oldest old should be 
studied further. 
Previous evidence on the association between multimorbidity and mortality in nonagenarians has been 
inconsistent [9, 10]. In line with our findings, a study with younger old people indicated that having at least 
three diseases increases the risk of death, and the effect is more pronounced in those with five or more 
diseases [22]. Comparisons between studies are difficult because of different ways of defining and 
measuring multimorbidity. However, our findings suggest that multimorbidity should be considered a 
predictor of mortality in the oldest old population.  
Due to their disabling effects, Parkinson’s disease, dementia, hip fracture and depression understandably 
increased the need for LTC as they do in younger old people [12, 13]. Our results emphasize the importance 
of dementia as the most important condition leading to LTC in the oldest old. Certain conditions previously 
associated with institutionalization (stroke, diabetes, heart disease, arthritis) [12, 13] did not affect LTC 
admission in our study, reflecting the importance of more disabling conditions in this age group: dementia, 
Parkinson’s disease and hip fracture. Multimorbidity as predictor of LTC admission [13] seems to hold in the 
oldest old women, as our results suggest. Consonant with previous studies [9, 13, 26, 27], our results also 
show that LTC admissions are more common in women than men whereas mortality is higher in men in this 
age group. This might be one reason why we did not find associations between chronic conditions or 
multimorbidity and LTC admission in men. 
The strength of this study is the study design, rarely used in studying the oldest old. A maximum of over 11 
years’ follow-up and use of time-dependent covariates provided information on the changes in morbidity 
and functional status. PAF added to this information by describing the significance of analyzed conditions. It 
is also noteworthy that the sample included both community-dwelling and institutionalized participants. 
Using proxy answers, data were available from those not able to answer themselves. The response rates in 
the Vitality 90+ Study have been very high. 
The most important limitation is that the information was mostly self-reported and except for data about 
functional status, there was no way to estimate the severity of conditions. However, it has been shown that 
even the oldest old are able to give sufficiently reliable information on their health status [28]. Another 
restriction is that to maintain sufficient response rates, the number of questions, including the number of 
conditions, was limited.   
Our findings indicate that even though baseline mortality in very old people is high, certain chronic 
conditions, such as heart disease, diabetes, dementia and depression, in addition to multimorbidity, are still 
significant predictors of mortality in nonagenarians. In general, morbidity is associated with disability, but in 
this study, multimorbidity, dementia, hip fracture and depression increased the risk of LTC admission in 
women independent of functioning. Future research should focus on comorbidities with dementia since its 
prevalence is expected to increase [23]. In addition, updated information on the progression of the 
prevalence and incidence of other chronic conditions in the oldest old population is needed. 
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Table 1. Baseline characteristics of the study population. % (n) of each variable if not stated otherwise. 
Baseline All Home at baseline 
 Women  Men  Women  Men  
Total number of participants 2,276 586 1,489 465 
Proxy answers 20.1 (456) 13.2 (77) 4.1 (60) 4.3 (20) 
Missing n 11 4 7 3 
Median age (range) 91 (90-107) 91 (90-102) 91 (90-107) 91 (90-102) 
Year of entry     
2001 31.6 (720) 29.4 (172) 27.5 (409) 28.8 (134) 
2003 16.3 (370) 18.1 (106) 16.7 (249) 16.8 (78) 
2007 23.9 (543) 24.6 (144) 24.0 (358) 24.7 (115) 
2010 28.3 (643) 28.0 (164) 31.8 (473) 29.7 (138) 
Occupation     
Upper non-manual 5.5 (125) 17.9 (105) 5.4 (80) 17.9 (83) 
Lower non-manual 28.6 (651) 25.6 (150) 30.4 (452) 27.1 (126) 
Skilled manual 33.3 (758) 44.5 (261) 34.6 (515) 43.7 (203) 
Unskilled manual 9.6 (219) 2.2 (13) 8.9 (132) 1.7 (8) 
Housewives 11.2 (254)  12.6 (188)  
Unknown occupation 11.8 (269) 9.7 (57) 8.2 (122) 9.7 (45) 
Living arrangements     
Living alone 53.1 (1,203) 37.6 (220) 78.3 (1,160) 47.2 (219) 
Living with someone 11.7 (264) 39.7 (232) 21.7 (321) 52.8  (245) 
in LTC 35.2 (797) 22.7 (133)   
Missing n 12 1 8 1 
Functional ability score median (IQR)  9 (6-13) 7 (5-11) 8 (6-14) 6 (5-14) 
Missing n 69 21 40 16 
Chronic conditions     
Hypertension 45.9 (1,030) 31.5 (182) 51.3 (753) 33.2 (152) 
Heart disease 54.1 (1,213) 51.6 (298) 53.8 (790) 51.3 (235) 
Dementia 41.6 (932) 38.6 (223) 26.7 (392) 32.2 (148) 
Stroke 7.1 (158) 6.1 (35) 4.4 (64) 4.4 (20) 
Diabetes 11.7 (262) 10.7 (62) 10.4 (153) 9.8 (45) 
Arthritis 41.3 (926) 28.0 (162) 45.8 (672) 28.6 (131) 
Parkinson’s disease 2.1 (47) 1.0 (6) 1.2 (18) 0.7 (3) 
Hip fracture 17.6 (395) 11.1 (64) 14.4 (212) 10.0 (46) 
Depression 23.3 (522) 18.3 (106) 16.8 (246) 15.5 (71) 
Missing n 32 8 21 7 
Number of conditions      
0 6.0 (134) 13.2 (76) 8.0 (117) 15.3 (70) 
1 19.7 (442) 26.6 (154) 22.1 (324) 28.2 (129) 
2 28.2 (633) 26.5 (153) 29.9 (439) 26.4 (121) 
3 24.9 (559) 23.0 (133) 23.8 (350) 21.2 (97) 
4+ 21.1 (474) 10.7 (62) 16.2 (238) 9.0 (41) 
Median (range) 2 (0-7) 2 (0-7) 2 (0-7) 2 (0-7) 
Missing n 32 8 21 7 
Functional ability score ranges from 5 to 20, higher score representing worse functional ability 
 Table 2. Associations of chronic conditions, multimorbidity and functional ability with mortality. Hazard ratios (HR) and 95% confidence intervals (CI) from 
Cox regression models 
 
Women 
  
Men 
          
 Model 1ᵃ Model 2ᵇ  Model 1ᵃ Model 2ᵇ         
 (n=2,216-2,255) (n=2,216)  (n=566-581) (n=566)         
 HR 95 % CI HR 95 % CI  HR 95 % CI HR 95 % CI          
Functional ability 1.12 1.10-1.13 1.10 1.09-1.12  1.15 1.13-1.17 1.15 1.12-1.18          
Hypertension 0.91 0.82-1.01 0.93 0.84-1.04  1.06 0.85-1.32 1.03 0.82-1.30          
Heart disease 1.34 1.21-1.48 1.35 1.22-1.50  1.46 1.20-1.77 1.25 1.02-1.54          
Dementia 1.68 1.52-1.86 1.20 1.07-1.33  1.75 1.44-2.12 1.30 1.05-1.61          
Stroke 1.66 1.40-1.98 1.18 0.98-1.41  1.59 1.08-2.33 0.90 0.60-1.36          
Diabetes 1.39 1.20-1.61 1.27 1.09-1.48  1.64 1.23-2.20 1.67 1.24-2.25          
Arthritis 0.84 0.76-0.93 0.80 0.72-0.90  0.78 0.62-0.97 0.68 0.53-0.85          
Parkinson's disease 1.26 0.91-1.76 1.02 0.73-1.43  1.11 0.52-2.36 0.37 0.17-0.82          
Hip fracture 1.12 0.99-1.26 0.91 0.80-1.03  1.24 0.94-1.63 0.94 0.70-1.27          
Depression 1.41 1.26-1.58 1.15 1.02-1.29  1.30 1.02-1.65 0.96 0.74-1.25          
 Model 3ᵃ Model 4ᶜ  Model 3ᵃ Model 4ᶜ          
 (n=2,255) (n=2,216)  (n=581) (n=566)          
Functional ability 1.12 1.10-1.13 1.11 1.10-1.12  1.15 1.13-1.17 1.15 1.12-1.18          
Multimorbidity                    
0 diseases ref.  ref.   ref.  ref.           
1 disease 1.64 1.20-2.24 1.38 1.01-1.90  1.63 1.10-2.43 1.56 1.03-2.35          
2 diseases 1.69 1.25-2.29 1.32 0.96-1.79  1.85 1.25-2.74 1.42 0.94-2.14          
3 diseases 2.27 1.68-3.07 1.53 1.12-2.08  2.08 1.40-3.08 1.40 0.92-2.12          
 4+ diseases 2.64 1.95-3.57 1.59 1.16-2.16  3.06 2.00-4.69 1.57 0.99-2.49          
ᵃSeparate model for each variable, adjusted for age and year of entry               
ᵇAll conditions and functional ability adjusted for age, year of entry and occupational status            
ᶜMultimorbidity and functional ability adjusted for age, year of entry and occupational status            
 
  
 
 
 
Table 3. Associations of chronic conditions, multimorbidity and functional ability with entering LTC. Regression models with mortality as a competing risk 
for LTC. Subhazard ratios (SHR) and 95% confidence intervals (CI) 
 
Women 
  
Men 
          
 Model 1ᵃ Model 2ᵇ  Model 1ᵃ Model 2ᵇ          
 (n=1,458-1,476) (n=1,444)  (n=450-461) (n=447)          
 SHR 95% CI SHR 95% CI  SHR 95% CI SHR 95% CI          
Functional ability 1.08 1.06-1.11 1.07 1.04-1.10  1.14 1.08-1.20 1.11 1.05-1.18          
Hypertension 0.98 0.84-1.15 0.98 0.83-1.17  0.97 0.64-1.45 1.07 0.68-1.68          
Heart disease 0.90 0.77-1.06 0.86 0.73-1.02  1.33 0.93-1.91 1.31 0.90-1.92          
Dementia 1.58 1.33-1.87 1.50 1.25-1.79  1.44 1.01-2.06 1.23 0.80-1.89          
Stroke 1.11 0.74-1.67 0.97 0.63-1.50  0.93 0.36-2.36 0.68 0.24-1.93          
Diabetes 1.01 0.78-1.32 1.01 0.77-1.34  0.82 0.43-1.55 0.74 0.36-1.50          
Arthritis 1.16 0.99-1.35 1.08 0.91-1.27  1.40 0.96-2.06 1.34 0.90-2.00          
Parkinson’s disease 3.05 1.92-4.82 2.36 1.40-3.97  0.41 0.48-3.49 0.51 0.05-4.88          
Hip fracture 1.52 1.24-1.86 1.42 1.14-1.75  1.21 0.71-2.06 1.27 0.72-2.24          
Depression 1.56 1.27-1.91 1.27 1.01-1.59  1.21 0.76-1.92 1.05 0.65-1.70          
 Model 3ᵃ Model 4ᶜ  Model 3ᵃ Model 4ᶜ          
 (n=1,458-1,476) (n=1,444)  (n=450-461) (n=447)          
Functional ability 1.08 1.06-1.11 1.08 1.05-1.11  1.14 1.08-1.20 1.10 1.04-1.17          
Multimorbidity                    
0 diseases ref.  ref.   ref.  ref.           
1 disease 1.32 0.92-1.91 1.34 0.91-1.97  0.84 0.48-1.49 0.90 0.49-1.66          
2 diseases 1.46 1.03-2.08 1.43 0.98-2.08  1.51 0.88-2.60 1.52 0.82-2.78          
3 diseases 1.76 1.23-2.51 1.64 1.12-2.40  1.52 0.84-2.74 1.57 0.83-3.00          
 4+ diseases 2.21 1.53-3.20 1.99 1.34-2.95  1.78 0.88-3.59 1.56 0.72-3.37          
ᵃ Separate model for each variable, adjusted for age and year of entry               
ᵇAll conditions and functional ability adjusted for age, year of entry, occupational status and living arrangements            
ᶜMultimorbidity and functional ability adjusted for age, year of entry,  occupational status and living arrangements          
